# Black Stone Minerals, L.P.: financial statements, quarterly

BSM · NYSE · CIK 1621434 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsm.md) · [Financials](/companies/bsm/financials.md) · [Filings](/companies/bsm/filings.md) · [Insiders](/companies/bsm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bsm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [137](/filings/0001628280-24-045189.md) | [136 d](/filings/0001621434-26-000018.md) | [117](/filings/0001628280-25-022559.md) | [115](/filings/0001621434-25-000108.md) | [103](/filings/0001621434-25-000133.md) | [104 d](/filings/0001621434-26-000018.md) | [115](/filings/0001628280-26-030534.md) | [107](/filings/0001628280-26-052686.md) | [105](/filings/0001621434-25-000133.md) | [95.2 d](/filings/0001621434-26-000018.md) | [124](/filings/0001628280-26-030534.md) | [122](/filings/0001628280-26-052686.md) |
| Operating income | $m | [62.0](/filings/0001628280-24-045189.md) | [148 d](/filings/0001621434-26-000018.md) | [64.0](/filings/0001628280-25-022559.md) | [68.5](/filings/0001621434-25-000108.md) | [93.1](/filings/0001621434-25-000133.md) | [47.5 d](/filings/0001621434-26-000018.md) | [17.2](/filings/0001628280-26-030534.md) | [122](/filings/0001628280-26-052686.md) | [94.1](/filings/0001621434-25-000133.md) | [74.9 d](/filings/0001621434-26-000018.md) | [16.6](/filings/0001628280-26-030534.md) | [110](/filings/0001628280-26-052686.md) |
| Interest expense | $m | [0.6](/filings/0001628280-23-035690.md) | [0.7 d](/filings/0001628280-24-005670.md) | [0.6](/filings/0001628280-24-021063.md) | [0.6](/filings/0001628280-24-035132.md) | [0.7](/filings/0001621434-25-000133.md) | [1.1 d](/filings/0001621434-26-000018.md) | [1.4](/filings/0001628280-26-030534.md) | [2.3](/filings/0001628280-26-052686.md) | [2.4](/filings/0001621434-25-000133.md) | [2.8 d](/filings/0001621434-26-000018.md) | [3.4](/filings/0001628280-26-030534.md) | [3.8](/filings/0001628280-26-052686.md) |
| Net income | $m | [62.1](/filings/0001628280-24-045189.md) | [148 d](/filings/0001628280-25-007730.md) | [63.9](/filings/0001628280-25-022559.md) | [68.3](/filings/0001621434-25-000108.md) | [92.7](/filings/0001621434-25-000133.md) | [46.3 d](/filings/0001628280-25-007730.md) | [15.9](/filings/0001628280-26-030534.md) | [120](/filings/0001628280-26-052686.md) | [91.7](/filings/0001621434-25-000133.md) | [72.2 d](/filings/0001621434-26-000018.md) | [13.3](/filings/0001628280-26-030534.md) | [106](/filings/0001628280-26-052686.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [56.0](/filings/0001628280-23-035690.md) | [70.3](/filings/0001628280-25-007730.md) | [40.5](/filings/0001628280-24-021063.md) | [26.7](/filings/0001628280-24-035132.md) | [21.0](/filings/0001628280-24-045189.md) | [2.5](/filings/0001621434-26-000018.md) | [2.4](/filings/0001628280-25-022559.md) | [2.5](/filings/0001621434-25-000108.md) | [2.9](/filings/0001621434-25-000133.md) | [1.5](/filings/0001628280-26-052686.md) | [11.6](/filings/0001628280-26-030534.md) | [1.7](/filings/0001628280-26-052686.md) |
| Current assets | $m | [167](/filings/0001628280-23-035690.md) | [193](/filings/0001628280-25-007730.md) | [146](/filings/0001628280-24-021063.md) | [115](/filings/0001628280-24-035132.md) | [109](/filings/0001628280-24-045189.md) | [78.5](/filings/0001621434-26-000018.md) | [88.3](/filings/0001628280-25-022559.md) | [93.4](/filings/0001621434-25-000108.md) | [85.2](/filings/0001621434-25-000133.md) | [95.6](/filings/0001628280-26-052686.md) | [95.7](/filings/0001628280-26-030534.md) | [89.0](/filings/0001628280-26-052686.md) |
| Total assets | $m | [1,234](/filings/0001628280-23-035690.md) | [1,267](/filings/0001628280-25-007730.md) | [1,232](/filings/0001628280-24-021063.md) | [1,217](/filings/0001628280-24-035132.md) | [1,213](/filings/0001628280-24-045189.md) | [1,219](/filings/0001621434-26-000018.md) | [1,239](/filings/0001628280-25-022559.md) | [1,268](/filings/0001621434-25-000108.md) | [1,270](/filings/0001621434-25-000133.md) | [1,336](/filings/0001628280-26-052686.md) | [1,338](/filings/0001628280-26-030534.md) | [1,366](/filings/0001628280-26-052686.md) |
| Current liabilities | $m | [33.8](/filings/0001628280-23-035690.md) | [25.8](/filings/0001628280-25-007730.md) | [27.4](/filings/0001628280-24-021063.md) | [27.1](/filings/0001628280-24-035132.md) | [19.5](/filings/0001628280-24-045189.md) | [30.4](/filings/0001621434-26-000018.md) | [65.3](/filings/0001628280-25-022559.md) | [29.0](/filings/0001621434-25-000108.md) | [19.5](/filings/0001621434-25-000133.md) | [24.6](/filings/0001628280-26-052686.md) | [41.0](/filings/0001628280-26-030534.md) | [23.7](/filings/0001628280-26-052686.md) |
| Total liabilities | $m | [60.6](/filings/0001628280-23-035690.md) | [49.5](/filings/0001628280-25-007730.md) | [55.9](/filings/0001628280-24-021063.md) | [56.4](/filings/0001628280-24-035132.md) | [44.5](/filings/0001628280-24-045189.md) | [89.5](/filings/0001621434-26-000018.md) | [174](/filings/0001628280-25-022559.md) | [165](/filings/0001621434-25-000108.md) | [145](/filings/0001621434-25-000133.md) | [207](/filings/0001628280-26-052686.md) | [265](/filings/0001628280-26-030534.md) | [252](/filings/0001628280-26-052686.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [117 d](/filings/0001628280-24-045189.md) | [134 d](/filings/0001621434-26-000018.md) | [104](/filings/0001628280-25-022559.md) | [100 d](/filings/0001621434-25-000108.md) | [93.2 d](/filings/0001621434-25-000133.md) | [91.0 d](/filings/0001621434-26-000018.md) | [64.8](/filings/0001628280-26-030534.md) | [80.5 d](/filings/0001628280-26-052686.md) | [99.8 d](/filings/0001621434-25-000133.md) | [65.1 d](/filings/0001621434-26-000018.md) | [62.6](/filings/0001628280-26-030534.md) | [93.0 d](/filings/0001628280-26-052686.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: not reported

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.